Premier Alternatives

ExoCoBio

Seoul, South Korea · Founded 2017 · Privately Held (backing)

Developer of regenerative medicine and biopharmaceuticals designed to create value for the healthy life of mankind. ExoCoBio is based in Seoul, South Korea and was founded in 2017. Its last known valuation is $510,000. It has raised $55.3 million.

Last price · $/share
—
Implied valuation
$510K
Total raised
$55.3M
Last round
—
No prints on record

No secondary trades in ExoCoBio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ExoCoBio with a free account
  • ·The complete investor list: 20 names
  • ·Watch ExoCoBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where ExoCoBio prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of ExoCoBio stock.